COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,237 Articles (22,733 medRxiv, 8,504 bioRxiv)

Most recent first Previous |  Page 1120: Articles 11191-11200  | Next

Healthcare workers' SARS-CoV-2 infection rates during the second wave of the pandemic: prospective cohort study
Wurtz, A. M., Kinnerup, M. B., Pugdal, K., Schlunssen, V., Vestergaard, J. M., Nielsen, K., Cramer, C., Bonde, J. P., Biering, K., Carstensen, O., Hansen, K. K., Dalboege, A., Flachs, E. M., Hansen, M. L., Thulstrup, A. M., Wurtz, E. T., Kjaersgaard, M., Christensen, M. W., Kolstad, H. A.
10.1101/2021.11.17.21266459 — Posted: 2021-11-21
SARS-CoV-2 testing in the community: Testing positive samples with the TaqMan SARS-CoV-2 Mutation Panel to find variants in real-time
Ashford, F., Best, A., Dunn, S., Ahmed, Z., Siddiqui, H., Melville, J., Wilkinson, S., Mirza, J., Cumley, N., Stockton, J., Ferguson, J., Wheatley, L., Ratcliffe, E., Casey, A., The COVID-19 Genomics UK (COG-UK) Consortium5, , Quick, J., Richter, A., Loman, N. J., McNally, A.
10.1101/2021.11.17.21266297 — Posted: 2021-11-21
Emergence and widespread circulation of a recombinant SARS-CoV-2 lineage in North America
Gutierrez, B., Castelan, H. G., da Silva Candido, D., Jackson, B., Fleishon, S., Ruis, C., Delaye, L., Rambaut, A., Pybus, O., Escalera-Zamudio, M.
10.1101/2021.11.19.21266601 — Posted: 2021-11-21
SARS-CoV2 serology assays: utility and limits of different antigen based tests through the evaluation and the comparison of four commercial tests
Gdoura, M., Halouani, H., Mrad, M., Sahli, D., Chamsa, W., Mabrouk, M., Ben Salem, K., Hogga, N., Triki, H.
10.1101/2021.11.19.21266615 — Posted: 2021-11-21
COVID-19 Health Care Behaviour in The Gambia: a cross-sectional survey of 205 adults who went through mandatory institutional quarantine
Johm, P., Nkereuwem, O. O., Manjang, A. M., Ceesay, O., Leigh, L., Ceesay, A., Bittaye, M., Roberts, A., Manjang, B., Sambou, S., Sanneh, S., Saidy, L., Saidy, B., Kampmann, B.
10.1101/2021.11.17.21266451 — Posted: 2021-11-21
Persistent Autoimmune Activation and Proinflammatory State in Post-COVID Syndrome
Acosta-Ampudia, Y., M Monsalve, D., Rojas, M., Rodriguez, Y., Zapata, E., Ramirez-Santana, C., Anaya, J.-M.
10.1101/2021.11.17.21266457 — Posted: 2021-11-21
Symptomatic and asymptomatic transmission of SARS-CoV-2 in K-12 schools, British Columbia, April to June 2021
Choi, A., Masse, L., Bardwell, S., Zhao, Y., Xu, Y. X. Z., Markarian, A., Coombs, D., Watts, A., Macdonald, A., Dhillon, N., Irvine, M., O'Reilly, C., Lavoie, P. M., Goldfarb, D. M.
10.1101/2021.11.15.21266284 — Posted: 2021-11-20
Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19
Pongracz, T., Nouta, J., Wang, W., van Meijgaarden, K. E., Linty, F., Vidarsson, G., Joosten, S. A., Ottenhoff, T. H. M., Hokke, C. H., de Vries, J. J. C., Arbous, S. M., Roukens, A. H. E., Wuhrer, M.
10.1101/2021.11.18.21266442 — Posted: 2021-11-20
A SARS-CoV-2 Delta Variant Containing Mutation in the Probe Binding Region Used for qRT-PCR Test in Japan Exhibited Atypical PCR Amplification and Might Induce False Negative Result
Rajib, S. A., Ogi, Y., Hossain, M. B., Ikeda, T., Tanaka, E., Kawaguchi, T., Satou, Y.
10.1101/2021.11.15.21266335 — Posted: 2021-11-20
Evaluation of a novel direct capture method for virus concentration n wastewater from COVID-19 infectious ward and correlation analysis with the number of inpatients.
Inaba, M., Nakao, R., Imamura, F., Nakashima, Y., Miyazono, S., Akamatsu, Y.
10.1101/2021.11.17.21266445 — Posted: 2021-11-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).